Dr Michael J Belmont, MD | |
2100 W Clinch Ave, Suite 410, Knoxville, TN 37916-2219 | |
(865) 521-6005 | |
(865) 521-6088 |
Full Name | Dr Michael J Belmont |
---|---|
Gender | Male |
Speciality | Otolaryngology - Pediatric Otolaryngology |
Location | 2100 W Clinch Ave, Knoxville, Tennessee |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043238348 | NPI | - | NPPES |
7521409 | Other | AETNA | |
BLUECROSSBLUESHIELD | Other | TN | 4061754 |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YP0228X | Otolaryngology - Pediatric Otolaryngology | MD37296 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael J Belmont, MD 2100 W Clinch Ave, Suite 410, Knoxville, TN 37916-2219 Ph: (865) 521-6005 | Dr Michael J Belmont, MD 2100 W Clinch Ave, Suite 410, Knoxville, TN 37916-2219 Ph: (865) 521-6005 |
News Archive
A team of researchers led by Richard Slatcher, Ph.D., associate professor of psychology in the College of Liberal Arts and Sciences at Wayne State University, has been awarded $2.74 million from the National Heart, Lung and Blood Institute of the National Institutes of Health for a project that aims to improve asthma management in youth.
Kaiser Health News provides a fresh take on health policy developments with "Fancy Footwear?" by Steve Kelley.
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
Researchers have found that men and women who feel sensitive to rejection based on their physical appearance are more likely to express interest in having cosmetic surgery than those who are less sensitive to appearance-based rejection. This effect is particularly true when people recall negative comments about their physical appearance.
MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported that the June 22, 2010 issue of Proceedings of the National Academy of Sciences USA included an article related to the mechanism of action of MN-166 (ibudilast), as an emerging therapeutic for neurological disorders.
› Verified 5 days ago
Dr. Nicholas John Panella, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9430 Park West Blvd Ste 330, Knoxville, TN 37923 Phone: 865-693-6065 | |
Dr. Clifford Q Johnson,jr, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9430 Park West Blvd, Ste 330, Knoxville, TN 37923 Phone: 865-693-6065 Fax: 865-531-6325 | |
Jameson Kyle Mattingly, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9430 Park West Blvd Ste 330, Knoxville, TN 37923 Phone: 865-693-6065 Fax: 865-531-6325 | |
Dr. Mark Thomas Gurley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 144 Concord Rd, Knoxville, TN 37934 Phone: 865-777-1727 Fax: 865-966-0942 | |
Dr. Joe Alan Graves, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2100 W Clinch Ave, Suite 330, Knoxville, TN 37916 Phone: 865-673-8229 Fax: 865-673-8893 | |
Dr. John P Little, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2100 W Clinch Ave Ste 410, Knoxville, TN 37916 Phone: 865-521-6005 Fax: 865-521-6088 |